Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 40 of 58, showing 10 Applications out of 576 total, starting on record 391, ending on 400

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

391.

ECCT/23/03/06   PDMC-II
    Dihydroartemisinin-piperaquine and azithromycin for the post-discharge management of children with severe anaemia in Malawi, Kenya and Uganda; A, multicentre, parallel-group, two-arm, randomised, double-blind superiority trial.   
Principal Investigator(s)
1. Simon Kariuki
2. Titus Kwambai
Site(s) in Kenya
Jaramogi Oginga Odinga Teaching and Referral Hospital
 
16-08-2023 View

392.

ECCT/23/04/04   AGREE
    Oral antenatal L-citrulline supplementation to reduce adverse pregnancy outcomes: a two-arm, randomized, placebo-controlled multi-site trial in Kenya   
Principal Investigator(s)
1. Hellen Barsosio
Site(s) in Kenya
1. Ahero County Hospital (Kisumu county)
2. Alupe sub-county Hospital (Busia county)
3. Siaya County Referral Hospital (Siaya county)
 
24-08-2023 View

393.

ECCT/23/06/04   ARNASA
    A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE       
Principal Investigator(s)
1. Dr Jacqueline Mirera
Site(s) in Kenya
1. Clinical Research Health Network (CREA-N) (Machakos county)
2. KEMRI-CRDR Siaya Clinical Research Annex (Siaya county)
3. KEMRI-Mtwapa Clinical Annex (Kilifi county)
4. Center for Research In Tropical Medicine and Community Development (Nairobi City county)
5. Center for Research In Tropical Medicine and Community Development (Nairobi City county)
6. University of Nairobi Clinical Research Centre (Nairobi City county)
7. KEMRI-CRDR Clinical Research Annex (Nairobi City county)
 
24-08-2023 View

394.

ECCT/23/05/08   ACTIV-2d/A5407
    A Phase 3, multicenter, randomized, double-blind, 24-week study of the clinical and antiviral effect of S-217622 compared with placebo in non-hospitalized participants with COVID-19    
Principal Investigator(s)
1. Dr John Kinuthia
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. Victoria Biomedical Research Institute, (Kisumu county)
3. Kenyatta National Hospital (Nairobi City county)
4. KEMRI CCR – BUTERE SITE (Kakamega county)
5. Kenya Medical Research Institute/Walter Reed Project (Kericho county)
6. KEMRI – AHERO Clinical Trials Unit (Kisumu county)
 
27-08-2023 View

395.

ECCT/23/07/04   PRAISE
    An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease (PRAISE)   
Principal Investigator(s)
1. Dr. Janet Oyieko
Site(s) in Kenya
1. Kondele Children\'s Hospital Center for Clinical Research (CCR), (Kisumu county)
2. Gertrude\'s Children Hospital (Nairobi City county)
3. KEMRI/CRDR Kemri Clinical Research Annex (Siaya county)
 
28-08-2023 View

396.

ECCT/23/07/05   Sabin
    A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Healthy Adults    
Principal Investigator(s)
1. Prof. Videlis Nduba Nduba Nzioka
Site(s) in Kenya
KEMRI / CRDR, KEMRI Clinical Research Annex, Siaya County Referral Hospital Ground. P.O BOX 144-40600 ,Siaya, Kenya
 
11-09-2023 View

397.

ECCT/23/05/07   LATA
    Long-Acting Treatment in Adolescents (LATA) A randomised open-label 2-arm 96 week trial in virologically suppressed HIV-1-positive adolescents aged 12-19 years of age in Sub-Saharan Africa   
Principal Investigator(s)
1. Abraham Siika
Site(s) in Kenya
1.
 
11-09-2023 View

398.

ECCT/23/05/04   PRIORITY Trial
    Prevention of Iron Deficiency Anemia Post-delivery   
Principal Investigator(s)
1. FABIAN OMODING ESAMAI
2. PAUL OBANDA NYONGESA
Site(s) in Kenya
BUSIA COUNTY REFERRAL HOSPITAL
 
18-09-2023 View

399.

ECCT/23/06/08   TSCV3000
    Age-descending, randomized, placebo-controlled Phase 2 trial in three sites in sub-Saharan Africa to assess the safety and immunogenicity of a parenteral Trivalent Salmonella (S. Enteritidis/S. Typhimurium/S. Typhi Vi) Conjugate Vaccine (TSCV) versus placebo   
Principal Investigator(s)
1. RICHARD ONYANDO OMORE
Site(s) in Kenya
1. SIAYA COUNTY REFERRAL HOSPITAL (Siaya county)
2. ST. ELIZABETH LWAK HOSPITAL (Siaya county)
 
25-09-2023 View

400.

ECCT/23/06/01   BREATHE
    Building Respiratory Support in East Africa Through High Flow versus Standard Flow Oxygen Evaluation   
Principal Investigator(s)
1. Elisabeth Riviello
Site(s) in Kenya
1. AIC Kijabe Hospital, Kiambu County (Kiambu county)
2. Nakuru Level 6 Hospital (Nakuru county)
 
04-10-2023 View